Biosimilar medicines in inflammatory bowel disease.
Bjørn
B
Moum
Knut E A
KE
Lundin
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use; D059451:Biosimilar Pharmaceuticals / Q000191:economics / Q000592:standards / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab; D013810:Therapeutic Equivalency
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D059451:Biosimilar Pharmaceuticals; D000069285:Infliximab